Advancing bladder cancer management: development of a prognostic model and personalized therapy

Advancing bladder cancer management: development of a prognostic model and personalized therapy

BackgroundBladder cancer (BLCA) was recognized as a significant public health challenge due to its high incidence and mortality rates. The influence of molecular subtypes on treatment outcomes was well-acknowledged, necessitating further exploration of their characterization and application. This st...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Xiang Huang, Guotu Du, Ying Yang, Peng Su, Shicheng Chen, Chongjiong Cai, Tianyu Huang, Yu Zeng, Yonggang Tao, Demei Tian, Neng Zhang
Format: Artykuł
Język:English
Wydane: Frontiers Media S.A. 2024-07-01
Seria:Frontiers in Immunology
Hasła przedmiotowe:
bladder cancer
molecular subtypes
basal squamous
prognostic model
single-cell RNA sequencing
personalized treatment
Dostęp online:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1430792/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1430792/full

Podobne zapisy